Anthem Denied Cancer Treatment? Here's How to Appeal

Why Anthem Denies Cancer Treatment Claims

Anthem, now operating under its parent name Elevance Health, administers Blue Cross Blue Shield plans across 14 states and is one of the largest health insurers in the United States. Despite covering millions of Americans, Anthem routinely denies cancer treatments — including chemotherapy regimens, clinical trial participation, and oncology drugs — citing clinical criteria that can feel impossible to meet when you're already fighting for your life. Understanding why these denials happen and how to appeal them is critical.

Anthem's cancer-related denials fall into several categories. First, Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization failures: Anthem requires pre-authorization for most chemotherapy regimens, targeted therapies, and immunotherapy drugs. Anthem evaluates these requests using its IndiGO clinical review system and published Clinical Criteria Documents available at anthem.com. If your oncologist selects a regimen that isn't on Anthem's preferred drug list or doesn't clearly align with NCCN (National Comprehensive Cancer Network) Category 1 evidence for your specific cancer type and stage, Anthem may deny coverage as "not medically necessary" or "experimental."

Second, clinical trial participation denials. While the Affordable Care Act requires most insurers to cover routine costs associated with approved clinical trials, Anthem has been known to narrowly define what qualifies as a "routine" cost — denying imaging, lab work, or supportive medications as trial-related expenses it doesn't have to cover.

Third, off-label drug use is a major denial trigger. Oncologists commonly prescribe FDA-approved drugs off-label based on clinical evidence. Anthem's Clinical Criteria Documents, available on anthem.com, outline which off-label uses Anthem considers medically necessary. If your specific cancer type or stage doesn't match those criteria exactly, denial is likely. Anthem's oncology policies reference NCCN guidelines and may also cite MCG Health (formerly Milliman) criteria for certain therapies.

Fourth, radiation modality disputes: Anthem frequently denies proton beam therapy, stereotactic body radiation therapy (SBRT), and other advanced radiation modalities, claiming conventional radiation is equally effective. These denials are contested when the clinical record shows specific reasons — such as proximity to critical structures, pediatric patients, or re-irradiation scenarios — where advanced modalities reduce toxicity.

Your Legal Rights

ACA requirements. ACA-compliant plans must cover cancer treatment as essential health benefits and must cover routine costs associated with qualifying clinical trials. Anthem cannot deny payment for standard care simply because a patient is enrolled in an approved clinical trial.

ERISA protections. For employer-sponsored plans, ERISA requires Anthem to provide a specific written explanation of the denial including the clinical reason and policy cited, access to the complete claims file, and a full and fair review on appeal. ERISA's "arbitrary and capricious" standard means Anthem must have substantial evidence supporting its denial.

NCCN guidelines. The NCCN Compendium is recognized by most states and courts as the definitive standard for cancer treatment. If your prescribed treatment is NCCN Category 1 for your cancer type and stage, this is your strongest evidence of medical necessity. Many states require coverage of off-label cancer drug use when the use is listed in the NCCN Compendium.

Expedited appeal rights. Cancer patients have the right to expedited appeal when treatment delay poses a serious health risk. Anthem must respond within 72 hours for expedited pre-service appeals.

External Independent Review: Complete Guide" class="auto-link">External review. After exhausting Anthem's internal appeals, you have the right to an IROs) Explained" class="auto-link">Independent Review Organization (IRO) review. The IRO decision is binding on Anthem in most states.

Anthem's Appeal Process Step-by-Step

Step 1: Request the denial letter and Anthem's clinical criteria. Anthem must provide an EOB)" class="auto-link">Explanation of Benefits (EOB) and a denial letter specifying the clinical reason and the policy cited. Request Anthem's full Clinical Criteria Document cited in the denial — available at anthem.com under "Clinical Criteria."

Step 2: File a first-level internal appeal immediately. You have at least 180 days from the denial date. Submit a written appeal with your oncologist's letter of medical necessity, relevant peer-reviewed literature, and the applicable NCCN guidelines. Request expedited processing — Anthem must respond within 72 hours.

Step 3: Address the specific denial reason. Your appeal letter should address Anthem's cited clinical criterion directly:

• For "not medically necessary": cite the NCCN Clinical Practice Guidelines category and your specific cancer presentation
• For off-label denials: cite the NCCN Compendium listing and applicable state mandate
• For clinical trial routine cost denials: identify the specific costs claimed to be excluded and cite the ACA clinical trial coverage requirement

Step 4: File a second-level internal appeal if denied. At this stage, Anthem is required to have a physician reviewer in the same or similar specialty as your treating oncologist review the case. If your oncologist is a subspecialized oncologist, request that the reviewer has the same subspecialty.

Step 5: Request external IRO review. After exhausting internal appeals, request IRO review. The IRO decision is binding on Anthem. Request a reviewer with oncology expertise in your specific cancer type.

Step 6: File a state insurance department complaint. If Anthem fails to follow proper timelines or denies an IRO ruling, file a complaint simultaneously with your state's Department of Insurance.

Documentation Checklist

• Oncologist letter: diagnosis (staging, TNM, molecular markers), prior treatment history, clinical rationale for current regimen
• NCCN Clinical Practice Guidelines citation (specify category rating — Category 1 is strongest)
• NCCN Compendium listing if off-label use
• Peer-reviewed journal articles supporting the regimen
• Prior treatment documentation: agents used, dates, response, and reason for discontinuation
• Pathology report with histology and relevant biomarkers
• Clinical trial registration (NCT number) if applicable
• Documentation of urgency: why treatment delay poses immediate health risk

State-Specific Notes

Anthem's cancer coverage policies vary by state. In California, Anthem Blue Cross members can use the DMHC's Independent Medical Review (IMR) process — faster and more consumer-friendly than federal IRO processes. In New York, Empire BlueCross BlueShield is subject to New York State's stringent external appeal laws. In Indiana and Georgia, where Anthem has significant employer group market share, state external review processes apply. Connecticut subscribers have robust state consumer protections. In states with oral chemotherapy parity laws, Anthem must cover oral cancer drugs with the same cost-sharing as IV chemotherapy.

Fight Back With ClaimBack

A cancer treatment denial from Anthem is not the final word — it is the beginning of a process that many patients successfully overturn. The problem is that most patients don't know how to navigate appeals while managing treatment, side effects, and fear. ClaimBack helps you build an appeal that cites the right NCCN guidelines, addresses Anthem's specific clinical criteria, and demonstrates clinical urgency — all in 3 minutes. When cancer is involved, every day matters.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal